Mass drug administration of praziquantel lowers the susceptibility of school-aged children to Schistosoma mansoni in endemic areas.
Saved in:
| Title: | Mass drug administration of praziquantel lowers the susceptibility of school-aged children to Schistosoma mansoni in endemic areas. |
|---|---|
| Authors: | Nono JK; Unit of Immunobiology and Helminth Infections, Laboratory of Molecular Biology and Biotechnology, Institute of Medical Research and Medicinal Plant Studies, Ministry of Scientific Research and Innovation, Yaoundé, Cameroon.; Division of Immunology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Bitye Zambo BM; Unit of Immunobiology and Helminth Infections, Laboratory of Molecular Biology and Biotechnology, Institute of Medical Research and Medicinal Plant Studies, Ministry of Scientific Research and Innovation, Yaoundé, Cameroon., Kameni Poumeni M; Unit of Immunobiology and Helminth Infections, Laboratory of Molecular Biology and Biotechnology, Institute of Medical Research and Medicinal Plant Studies, Ministry of Scientific Research and Innovation, Yaoundé, Cameroon.; Department of Microbiology and Parasitology, University of Bamenda, Bambili, Cameroon., Soh Bayeck EB; Department of Biochemistry, Faculty of Science, University of Yaoundé 1, Yaoundé, Cameroon., Meyo Kamguia L; Unit of Immunobiology and Helminth Infections, Laboratory of Molecular Biology and Biotechnology, Institute of Medical Research and Medicinal Plant Studies, Ministry of Scientific Research and Innovation, Yaoundé, Cameroon.; Ecole Doctorale Regionale (EDR) d'Afrique Centrale en Infectiologie Tropicale, Université des Sciences et Techniques de Masuku (USTM), Franceville, Gabon., Noubissi Fotseu MM; Unit of Immunobiology and Helminth Infections, Laboratory of Molecular Biology and Biotechnology, Institute of Medical Research and Medicinal Plant Studies, Ministry of Scientific Research and Innovation, Yaoundé, Cameroon.; School of Health Sciences, Catholic University of Central Africa, Yaoundé, Cameroon., Owona Ayissi VB; Department of Biochemistry, Faculty of Science, University of Yaoundé 1, Yaoundé, Cameroon., Spangenberg T; Global Health Research and Development of the Healthcare Business of Merck KGaA, Darmstadt, Germany, Ares Trading S.A. (An Affiliate of Merck KGaA, Darmstadt, Germany), Eysins, Switzerland., Demarta-Gatsi C; Global Health Research and Development of the Healthcare Business of Merck KGaA, Darmstadt, Germany, Ares Trading S.A. (An Affiliate of Merck KGaA, Darmstadt, Germany), Eysins, Switzerland. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Feb 25; Vol. 17, pp. 1746003. Date of Electronic Publication: 2026 Feb 25 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1746003 |
